Niranjan Kanesa-thasan, Chief Medical Officer at Icosavax, Inc. (ICVX), bought 48,166 shares at $15.00 ($722K) on 2021-08-02, disclosed to the SEC on 2021-08-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 41,500 | $623K | 86.2% |
| 2 | $15.00 | 6,666 | $100K | 13.8% |
| Total | $15.00 avg | 48,166 | $722K | 100% |
| Filing → |
| ICVX | SELL | 2023-08-01 | $29K | — | Filing → |
| ICVX | SELL | 2023-02-15 | $19K | — | Filing → |
| ICVX | SELL | 2022-08-02 | $22K | — | Filing → |